Addressing Your Clinical Needs in Graves’ Disease Diagnostics
B·R·A·H·M·S TRAK human – the Gold Standard in Diagnosis, Prognosis and Follow-up
Graves' disease is an autoimmune thyroid disease that is characterized by the clinical symptoms of goiter, tachycardia and exophthalmus (abnormal protrusion of the eyeballs). From a differential diagnosis point of view, Graves' disease must be distinguished from the functional autonomy of the thyroid since the former can initially be treated by the application of drugs while the latter should be treated by surgery or radioiodine therapy. The measurement of the TSH receptor antibody concentration (TRAK) is key to detecting and adequately treating Graves' disease.
With the introduction of the highly sensitive Thermo Scientific B·R·A·H·M·S TRAK human KRYPTOR assay in 1999, using immobilized recombinant human TSH receptors, a definite improvement for differential diagnosis of Graves' disease was achieved. This assay ensures that a greater number of patients can be adequately treated at an early stage and that the treatment success can be controlled.
Find out below how our product can help you in the clinical care of your patients or contact us directly.
B·R·A·H·M·S TRAK human for your clinical practice:
B·R·A·H·M·S TRAK human for your lab:
More information on B·R·A·H·M·S TRAK human in Graves' disease
- EN: TRAK human, the Gold Standard in Graves’ disease, Background info on Graves’ disease and application of B·R·A·H·M·S TRAK human
- EN: Clinical Brochure on Graves’ disease highlighting clinical details and benefits of B·R·A·H·M·S TRAK human